Market closed
IRIDEX/$IRIX
IRIDEX shares are trading lower after the company held its Q1 2025 earnings call.
11 hours ago·Lightyear AI
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About IRIDEX
IRIDEX Corp is involved in the business of developing, manufacturing, and marketing laser-based medical systems, delivery devices, and consumable instrumentation for ophthalmology. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.
Ticker
$IRIX
Sector
Trading on
Industry
Health Care Equipment & Supplies
Headquarters
Employees
93
ISIN
US4626841013
Website
IRIDEX Metrics
BasicAdvanced
$18M
-
-$0.54
0.74
-
Price and volume
Market cap
$18M
Beta
0.74
52-week high
$1.45
52-week low
$0.78
Average daily volume
76K
Financial strength
Current ratio
1.423
Quick ratio
0.651
Long term debt to equity
86.552
Total debt to equity
221.412
Management effectiveness
Return on assets (TTM)
-16.32%
Return on equity (TTM)
-153.37%
Valuation
Price to revenue (TTM)
0.372
Price to book
8.73
Price to tangible book (TTM)
-104.57
Price to free cash flow (TTM)
-2.478
Growth
Revenue change (TTM)
-6.17%
Earnings per share change (TTM)
-8.66%
3-year revenue growth (CAGR)
-3.35%
3-year earnings per share growth (CAGR)
16.82%
IRIDEX News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for IRIDEX stock?
IRIDEX (IRIX) has a market cap of $18M as of May 15, 2025.
What is the P/E ratio for IRIDEX stock?
The price to earnings (P/E) ratio for IRIDEX (IRIX) stock is 0 as of May 15, 2025.
Does IRIDEX stock pay dividends?
No, IRIDEX (IRIX) stock does not pay dividends to its shareholders as of May 15, 2025.
When is the next IRIDEX dividend payment date?
IRIDEX (IRIX) stock does not pay dividends to its shareholders.
What is the beta indicator for IRIDEX?
IRIDEX (IRIX) has a beta rating of 0.74. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.